Gmail users: to ensure you're always viewing the entire newsletter, check at the bottom of the email to see if the newsletter has been "clipped" and click "view entire message" if so.
|
|
VeloSano 8 Kicks-off Today!
|
|
VeloSano's "Bike to Cure" weekend starts today, September 10-11! This event raises money for innovative cancer research in Cleveland, and your support is appreciated!
We wish all the riders a fun, safe ride! There is still time to show your support by donating to #TeamCaseCCC or cheering the riders at our cheer station!
|
|
Go #TeamCaseCCC!
Our wonderful riders and virtual fundraisers join us from all Case Comprehensive Cancer Center partners - University Hospitals, Seidman Cancer Center, Case Western Reserve University and the Cleveland Clinic - and represent a wide spectrum of professions from physicians, researchers, physician-researchers, hospital administrators, graduate students, to family and friends who are passionate for the cause.
Our vision and hope for the future is strong VeloSano support and representation from our Case Comprehensive Cancer Center partner organizations, supporting cancer research, funding, and promoting awareness and unity across our institutions. Join our effort and help us make VeloSano 8 our biggest year yet!
Look for #TeamCaseCCC wearing these jerseys (modeled above by Team Captain Mary Wright)!
|
|
Share your Photos with Us!
We are so excited to see all the photos and share in the excitement of VeloSano 8! Tag @caseccc ( Facebook, Instagram, Twitter) or use #TeamCaseCCC if you post on social media. Send photos and/or comments to cancer@case.edu, and we will re-share them on our social media channels.
|
|
Volunteers Wanted: Cheer Station
Join the Case Comprehensive Cancer Center at a Cheer Station on Saturday, September 11, from 11a-3p. Volunteer shifts are either two or two and a half hours. We will cheer on VeloSano 100-Mile, 50-Mile & 25-Mile riders by ringing cowbells, holding signs, and making noise to keep everyone motivated. Children are welcome!
|
|
Cancer Center Seminar Series: Starts TODAY, September 10
|
|
The Cancer Center Seminar Series will commence for the 2021-2022 academic year on September 10 at 12p in the Wolstein Research Building Auditorium (WRB 1-413). This interdisciplinary seminar series addresses cutting-edge clinical, translational, and basic research topics in cancer and is a focal point of the educational and inter-programmatic activities of the Cancer Center. CME credit is available for those who attend seminars.
We hope to see you in person to ask questions and engage with our invited speakers!
Seminars will also be accessible through Zoom during the presentation. Seminars will not be available for viewing at a later date.
|
|
September 10: "Targeting actin-regulatory protein in clear cell renal cancer"
|
|
Associate Professor, Bioengineering and Pathology
University of Pittsburgh
Presented by the Molecular Oncology Program
|
|
Dr. Roy is a bioengineer cross-trained in cell biology with overall research interests in cell migration, cancer biology and angiogenesis. His laboratory studies actin-binging proteins and their regulation, MRTF-SRF transcriptional axis, fundamental mechanisms of cell migration, cancer biology (breast and renal cancer), cell signaling and angiogenesis (in both developmental and pathological settings). For these studies, his lab uses a variety of experimental approaches including RNAi, protein-protein interaction, 2D gel electrophoresis, genetically engineered mouse models of cancer and angiogenesis, tumor xenografts, metastasis assays, in vitro, ex vivo and in vivo angiogenesis assays, genomics and proteomics, live-cell imaging at single cell level, small molecule screening and bioinformatics.
|
|
September 17
"The liver microenvironment in metastatic colorectal cancer"
Assistant Professor, Department of Surgery
Member, Developmental Therapeutics Program, Case Comprehensive Cancer Center
Case Western Reserve University School of Medicine
Presented by the Developmental Therapeutics Program
**Seminar will be held in BRB 105
|
|
September 24
"Quantitative Modeling of Cancer Evolution in silico and in vivo"
Assistant Professor, Department of Genetics and Genome Sciences
Assistant Professor, Case Comprehensive Cancer Center
Member, Cancer Genomics Program, Case Comprehensive Cancer Center
Case Western Reserve University School of Medicine
Presented by the Cancer Genomics Program
|
|
Computational Method Identifies Chromatin Loops at Single-Cell Resolution
|
|
According to new findings published in Nature Methods, a team of researchers co-led by Ming Hu, PhD, assistant staff in the Department of Quantitative Health Sciences at the Cleveland Clinic and member of the Cancer Genomics & Epigenomics Program of the Case Comprehensive Cancer Center, and Bing Ren, PhD, Professor of Cellular and Molecular Medicine at the University of California, San Diego, have developed a novel computational method, called SnapHiC, to study chromatin spatial organization in single cells of complex human tissues.
Chromatin is the material within chromosomes that contain DNA and proteins. The 23 pairs of human chromosomes, which measure six-feet long in total length, are packed into an extremely small cellular compartment called the nucleus. In order to fit within this tiny space, the chromatin fibers have to be folded very carefully in a way that does not impede critical cellular processes, such as gene expression and DNA replication. Dysregulation of chromatin folding has been implicated in various diseases.
“While single cell genomics technologies exist to map chromatin architecture in individual cells of complex tissues, it is still challenging to map chromatin loops at high resolution,” said Hu. “We developed a computational method named SnapHiC that harnesses data generated from existing technologies to more accurately identify chromatin loops at high resolution in single cells.”
|
|
Case Comprehensive Cancer Center joins national effort urging vaccination to protect against HPV and other diseases
|
|
NCI-designated cancer centers, AACI members and other cancer centers and medical groups endorse HPV vaccination and cancer screening to eliminate cancers caused by the virus.
The Case Comprehensive Cancer Center - a partnership of Case Western Reserve University, Cleveland Clinic and University Hospitals - joins with 15 leading academic and freestanding cancer centers with membership in the Association of American Cancer Institutes (AACI), all National Cancer Institute (NCI)-designated cancer centers—among them 70 AACI members—and other organizations have issued a joint statement urging the nation’s health care systems, physicians, parents, children and young adults to get human papillomavirus (HPV) vaccinations and other recommended vaccinations back on track.
The organizations urge the following actions as children head back to school:
- Health care systems’ staff and providers should immediately identify and contact parents of adolescents who are due for vaccinations and encourage them to complete vaccinations.
- Parents should have their adolescent children vaccinated as soon as possible. A list of recommended vaccines is available on the U.S. Centers for Disease Control and Prevention (CDC) website.
- Dramatic drops in annual well-child visits and immunizations during the COVID-19 pandemic have caused a significant vaccination gap and lag in vital preventive services among U.S. children and adolescents. HPV vaccinations have been especially affected. The pandemic also has increased health disparities, leaving underserved adolescents at even greater risk for missed doses of this cancer prevention vaccine.
|
|
Request for Applications: Nominations for F99/K00 Award for Training Predoctoral/Postdoctoral Transitions
|
|
The National Cancer Institute will be announcing a Request for Applications for the Predoctoral to Postdoctoral Fellow Transition (F99/K00) Award for 2021, to support outstanding PhD candidates as they complete their dissertation research training (F99 phase; 1-2 years) and transition to a mentored, cancer-focused postdoctoral career development research positions (K00 phase – up to 4 years). The F99/K00 award is open to 3rd or 4th year PhD students, including F31 Fellowship applicants and current awardees (note that 3rd or 4th year students would have matriculated in 2018 or 2019). International students may also apply. Students Matriculated in a dual-degree program (e.g.) MD/PhD, DO/PhD, DDS/PhD, or DVM/PhD) are not eligible for the F99/K00 program. Projects must be clearly focused on cancer.
To apply for this award, an applicant must be nominated by their institution. As each institution is allocated only one nomination, the Case Comprehensive Cancer Center (Case CCC) requires potential applicants to assemble a pre-application.
|
|
Eligibility
- Open to 3rd or 4th year PhD students, including F31 Fellowship applicants and current awardees (3rd or 4th-year students would have matriculated in 2015 or 2016).
- International students may apply.
- Students in a dual-degree program (e.g. MD/ PhD , DO/ PhD , DDS/ PhD , or DVM/ PhD ) are not eligible.
Deadlines
Internal Competition Deadline: Sunday, September 12, 2021 by midnight.
Anticipated Deadline for NIH Letter of Intent (submitted by institution): November 4, 2021
Anticipated Deadline for Proposal Submission to NIH: December 4, 2021
|
|
Mon, Sep 13
GMI Seminar Series
|
|
Tues, Sep 14
Radiation Oncology Grand Rounds Lecture Series
8:15a Lerner B-151
MetroHealth Research-in-Progress and Seminar Series
|
|
Fri, Sep 17
Taussig Cancer Institute Grand Rounds
8a
Early Lesions Working Group
Cancer Center Seminar Series
12p BRB 105 (**note location)
|
|
Sat, Sep 18
Lessons from the Thoracic Tumor Board: Multidisciplinary Discussions, Debates, and Treatments
8a Livestream
|
|
|
Tues, Sep 21
Radiation Oncology Grand Rounds Lecture Series
8:15a Lerner B-151
MetroHealth Research-in-Progress and Seminar Series
|
|
Wed, Sep 22
Case CCC Cancer Imaging
|
|
Thurs, Sep 23
Affordable Cancer Technology (ACT 2021) Conference
Biochemistry Guest Speaker
4p SOM W428
|
|
Fri, Sep 24
Affordable Cancer Technology (ACT 2021) Conference
Taussig Cancer Institute Grand Rounds
8a
Early Lesions Working Group
Cancer Center Seminar Series
12p WRB 1-413
|
|
|
|
Affordable Cancer Technologies (ACT) Conference 2021
September 23-24, 2021 | Virtual
|
The Affordable Cancer Technology (ACT 2021) Conference is a global oncology virtual event that is open to the public for the very first time. The focus will be the intersection of technological innovation, cancer research, and global disparities, and it will bring together researchers, public health experts, policy advocates, and industry partners from all over the world. Panels of world-renowned experts will discuss the development of new technologies for LMICs, conducting cancer research in low-resource settings, and promoting scale-up and sustainability of cancer prevention programs. Dr. Tedros Adhanom, the Director-General of the World Health Organization, will be opening the conference.
To ensure diversity and inclusion, discounted and waived registration are available for selected LMIC researchers and students.
This event is sponsored by Case Western Reserve University and presented by Basic Health International. This conference was made possible by an award from the National Institutes of Health (R13 CA254456-01). CME credits are available.
|
|
|
|
|
Great Lakes Breast Cancer Symposium
October 25-26, 2021 | Virtual
|
This annual symposium highlights ongoing basic, translational, clinical and population studies addressing the biological mechanisms, management and prevention of breast cancer. Researchers from participating institutions will share their exciting work with a goal to develop cross-institutional collaborations.
Program topics include: therapeutics-response resistance, survivorship and disparities, metastasis, cancer cell biology, and microenvironment and immunology.
|
Keynote Presentation: "Tackling resistance in triple-negative breast cancer"
Helen Piwnica-Worms, PhD, will deliver a keynote at the symposium. Dr. Piwnica-Worms is Professor, Department of Experimental Radiation Oncology, Division of Radiation Oncology and Senator AM Aiken Jr. Distinguished Chair at University of Texas MD Anderson Cancer Center.
Thanks to our Sponsors and Exhibitors
Seagen, Pfizer Oncology, Lilly Oncology, Genentech and Puma Biotechnology.
|
|
|
|
REGISTRATION AND ABSTRACT SUBMISSION NOW OPEN: Artificial Intelligence in Oncology Symposium
November 8-9, 2021 | Virtual
|
Now in its third year, the 2021 Artificial Intelligence in Oncology Symposium: Precision Medicine and Cancer Disparities will bring together clinicians, biomedical engineers, computer scientists, executives, thought leaders, and entrepreneurs with expertise in precision medicine, AI, machine learning, and oncology. These experts will discuss technical advances in AI, the challenges and advancements in deploying AI in the clinic, the need for the use of AI to address health disparities, the current regulatory and reimbursement landscape for AI in medicine, and the potential of AI to impact global health.
For the health and safety of all attendees, this year's symposium will again take place virtually. Registration for the symposium is open now!
|
Keynote Address
Rohit Bhargava, PhD
Director and Professor, Bioengineering, Founder Professor of Engineering; Director of the Cancer Center, University of Illinois at Urbana-Champaign
|
Call for Abstracts: Now Open!
All students, postdocs, residents and fellows conducting research in Artificial Intelligence in Oncology are invited to submit abstracts. A committee will review abstracts based on the relationship to cancers and AI, novelty, significance of findings, and clarity.
Deadline: September 24, 2021
|
|
|
|
Additional Upcoming Events
|
|
|
Save the Date: Fall 2021 NIH Virtual Seminar on Program Funding and Grants Administration
November 1-4, 2021 | Virtual
|
The National Institutes of Health invites you to take part in a unique opportunity to learn more about working with the NIH grants process, programs, policies, and staff at the 2021 NIH Virtual Seminar on Grants Administration and Program Funding.
If you are an administrator, researcher, early-stage investigator, graduate student, or anyone new to working with the NIH grants process, then this seminar is designed specifically for you.
If you are more experienced then attend the policy updates and case study series.
Registration is free!
|
|
|
|
|
22nd Annual Brain Tumor Update and the 11th Annual Symposium on Brain Metastases and Spine Tumors
October 29-30, 2021 | Livestream
|
This symposium is co-provided by Cleveland Clinic and Keck School of Medicine of the University of Southern California. This advanced multidisciplinary virtual meeting is led by expert faculty from Cleveland Clinic and USC, with additional internationally recognized guest faculty. This symposium is designed to improve competence to assess and treat patients with brain tumors and primary tumors of the spine, especially as it relates to comparing treatments for brain metastases and primary spine tumors, evaluating new technologies, treating vestibular schwannomas, and assessing and treating gliomas, with the overall goal of improving outcomes in these patient populations.
|
|
|
|
8th Annual Multidisciplinary Colorectal Oncology Course
October 22, 2021 | Livestream 9am-12:30p
|
This symposium will focus on providing an in-depth and up-to-date review of the multidisciplinary management of colorectal cancers.
Oncologists, surgeons, radiation oncologists, and nurses with an interest in the management of patients with colorectal cancer should participate in this course.
MOC Credit Available
|
|
|
|
|
8th Annual Genetics Education Symposium
September 30, 2021 | Live Stream 8a-4:45p ET
|
This accredited program, presented by Cleveland Clinic’s Genomic Medicine Institute (GMI) and the Center for Personalized Genetic Healthcare (CPGH), will provide the opportunity to review the latest advances in genetics and genomics. GMI and CPGH will provide state-of-the-art information to healthcare providers treating patients with hereditary cancer syndromes.
Expert Cleveland Clinic and guest faculty will present case- and research-based presentations highlighting the integration of genetics and genomics into clinical practice.
Invited are practitioners and healthcare professionals seeking to learn the latest developments in medical genetics, especially providers in Hematology/Oncology, Genetics, Internal Medicine and Subspecialties, Pediatrics, and Nursing. Trainees and students with an interest in expanding their knowledge of genomic medicine and related topics are also encouraged to attend.
|
|
|
|
The AACR has a number of scientific conferences scheduled for the fall and winter that may be of interest:
Sept. 14-15, 2021
Sept. 29-30, 2021
Oct. 5-6, 2021
Oct. 6-8, 2021
Oct. 7-10, 2021
Oct. 21-22, 2021
Oct. 25-26, 2021
Dec. 7-10, 2021
|
|
|
|
September 23, 2021 | BRB 105 and Zoom
The Veale Institute for Entrepreneurship is kicking off a series of three seminars on commercializing biomedical research. The first is scheduled for September 23 at 4pm with Will Lewis, chairman & CEO of Insmed. Lewis will be joined by Chris Bailey-Kellogg, executive director of Computational Biology, and Karl Griswold, executive director of Biologics Research, two Dartmouth College faculty members who recently commercialized their research and had their company acquired by Insmed. Engage in discussion and hear the acquisition story of Stealth Biologics, LLC, from research to patient impact through commercialization.
|
|
Deadline: September 24, 2021
|
The Cigna Foundation is committed to eliminating health disparities and improving health and well-being for all. For this grant cycle, we’re looking to partner with nonprofits who are addressing the root causes of health inequity, including supporting under-resourced and systemically disadvantaged communities with poor social determinants of health.
Programs should focus on chronic disease treatment and prevention, mental and/or behavioral health conditions, dental health, wellness programs, and maternal, prenatal, and newborn health.
|
|
Deadline: October 15, 2021
Junior faculty members and established faculty wishing to refocus are invited to submit proposals for career development projects of up to $40,000 to be funded by the Case Comprehensive Cancer Center (Case CCC) - Tazania - Uganda HIV-associated Lung Cancer Collaborative. This training program is funded by the NCI U54 mechanism and is a collaboration between Case Western Reserve University (CWRU), the Case CCC, University Hospitals (UH), Makerere University, the Joint Clinical Research Center (JCRC), Uganda Cancer Institute, National Institute for Medical Research (NIMR) Tanzania, Muhimbili National Hospital, and the Ocean Road Cancer Institute (ORCI). Full-time faculty at or above instructor-level at any of the aforementioned institutions are eligible.
|
|
WKYC-TV 3 - Sep 8, 2021
Today is WKYC Studios' VeloSano Day of Giving. Nicole Peters discusses the fundraising event. 100% of every dollar raised in VeloSano goes toward life-changing cancer research at the Cleveland Clinic and the Case Comprehensive Cancer Center.
|
|
OncLive - Sep 2, 2021
Pradnya D. Patil, MD, FACP, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, discusses data from the phase 3 ADAURA trial (NCT02511106) in patients with EGFR-mutated non–small cell lung cancer (NSCLC).
|
|
Weekly NIH Funding Opportunities and Notices
|
|
Funding Opportunities
Notices
|
|
Use the button below to submit all your news, publications, events, announcements, lab openings and communications requests to the Case CCC Marketing and Communications team! We are here to help.
|
|
|
|
|
|
|